表 1.
胃癌组织中PFN2表达情况与临床特征的关系
Relationship between PFN2 expression in gastric cancer tissues and clinical features of the patients
| Feature | Cases | PFN2(n) | Pearson χ2 | P | |
| Low | High | ||||
| *P < 0.05. | |||||
| A11 | 94 | 48 | 46 | ||
| Gender | 0.640 | 0.424 | |||
| Male | 61 | 33 | 28 | ||
| Female | 33 | 15 | 18 | ||
| Age(year) | 0.650 | 0.420 | |||
| ≤60 | 31 | 18 | 13 | ||
| > 60 | 61 | 30 | 31 | ||
| Tumor diameter(cm) | 0.174 | 0.677 | |||
| ≤5 | 46 | 22 | 24 | ||
| > 5 | 46 | 24 | 22 | ||
| T-stage | 0.005 | 0.942 | |||
| T1/T2 | 13 | 7 | 6 | ||
| T3/T4 | 71 | 39 | 32 | ||
| N-stage | 0.322 | 0.570 | |||
| N0/N1 | 40 | 22 | 18 | ||
| N2/N3 | 53 | 26 | 27 | ||
| M-stage | 5.066 | 0.024* | |||
| M0 | 85 | 46 | 39 | ||
| M1 | 8 | 1 | 7 | ||
| AJCC-stage | 5.221 | 0.156 | |||
| Ⅰ | 9 | 5 | 4 | ||
| Ⅱ | 30 | 17 | 13 | ||
| Ⅲ | 46 | 24 | 22 | ||
| Ⅳ | 8 | 1 | 7 | ||